Mitogen-Activated Protein Kinase 1 (MAPK1) (N-Term) Peptide
Quick Overview for Mitogen-Activated Protein Kinase 1 (MAPK1) (N-Term) Peptide (ABIN5624601)
Target
Source
Application
-
-
Peptide Type
- Synthetic
-
Protein Region
- N-Term
-
Supplier Product No.
- 000-001-gp1
-
Supplier
- Rockland
-
Purpose
- ERK2 C-Term Blocking Peptide
-
Characteristics
- MAPK1, ERK, ERK-2, ERK2, MAPK2, P42MAPK, PRKM1, PRKM2, ERK-2 Blocking peptide, ERK-2 Control peptide
-
Purification
- Purity was determined to be greater than 95% specific peptide by analysis by HPLC and by reducing and non-reducing SDS-PAGE.
-
Purity
- Greater than 95% specific peptide by analysis by HPLC and by reducing and non-reducing SDS-PAGE.
-
-
-
-
Application Notes
-
Application Note: ERK2 N-term blocking peptide is suitable as a control for polyclonal or monoclonal Anti-ERK2 in immunological assays.
Western Blot Dilution: 50 ng
Other: Dot Blot
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
-
Reconstitution Buffer: Restore with deionized water (or equivalent)
Reconstitution Volume: 50μL
-
Concentration
- 1.0 mg/mL
-
Buffer
-
Buffer: None
Stabilizer: None
Preservative: 0.01 % (w/v) Sodium Azide -
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store vial at 2-8 °C prior to opening. Aliquot contents and freeze at -20 °C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. Dilute only prior to immediate use.
-
Expiry Date
- 6 months
-
-
- ERK2 (MAPK1) (Mitogen-Activated Protein Kinase 1 (MAPK1))
-
Background
-
Synonyms: MAPK1, ERK, ERK-2, ERK2, MAPK2, P42MAPK, PRKM1, PRKM2, ERK-2 Blocking peptide, ERK-2 Control peptide
Background: Mitogen activated protein kinase 1, also known as MAPK1, ERK, or ERK2, is an integral component of the MAP kinase cascade that regulates cell growth and differentiation. ERK1 and ERK2 are activated by MEK1 and MEK2 in the B-raf signaling pathway resulting in its translocation to the nucleus where it phosphorylates nuclear targets. Human ERK1 and ERK2 are 84 % identical in sequence and share common functionality in cells. ERK2 is ideal for investigators involved in Neuroscience, Cell Signaling and Cancer Research.
-
UniProt
- P28482
Target
-
